Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

NewsGuard 100/100 Score

Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics.  The agreement expands the availability of Goodfellow's products to new regions worldwide through the Aldrich® Materials Science initiative.

Under the agreement, Sigma-Aldrich will immediately begin distribution of more than 10,000 Goodfellow products, many of which are exclusive to Goodfellow. The offer will expand to include Goodfellow's entire portfolio of 70,000 products within the coming months.  Applications of the materials include medical devices, advanced electronics, electromagnetic shielding, x-ray technology, alternative energy and many other scientific and industrial areas.

According to Bryce P. Nelson, Initiative Lead for Aldrich Materials Science, "The addition of the Goodfellow portfolio expands Sigma-Aldrich's robust family of products for engineers and materials scientists.  These products complement our current metals and ceramics offering and are aligned with our strategic focus areas."

"Sigma-Aldrich is the global leader in providing materials to the research market," said Stephen Aldersley, Managing Director of Goodfellow.  "With operations in nearly forty countries, Sigma-Aldrich can provide researchers global access to our portfolio of products.  Improved availability of metals, alloys, ceramics and materials in general to researchers worldwide can enable continued growth in very important research areas."

Under the terms of the agreement, Aldrich Materials Science can market and distribute the materials immediately in most geographies, with all products available globally beginning in April 2015.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diet's role in fighting vitiligo highlighted in new research